Pharmaceutical

Glaxosmithkline Pharmaceuticals Ltd Q3FY25; 400% rise in Profits

Glaxosmithkline Pharmaceuticals Ltd Q3FY25; 400% rise in ProfitsGlaxosmithkline Pharmaceuticals Ltd Q3FY25; 400% rise in Profits

GlaxoSmithKline Pharmaceuticals research, manufacture and make available a broad range of medicines and vaccines that benefit people.(Source : Company Web-site)…

ERIS Lifesciences Ltd Q3FY25; 14% fall in Profits

ERIS Lifesciences Ltd Q3FY25; 14% fall in ProfitsERIS Lifesciences Ltd Q3FY25; 14% fall in Profits

ERIS Lifesciences Ltd is engaged in the business of manufacture and marketing of pharmaceutical products. Financial Results: ERIS Lifesciences Ltd…

Dr Lal Pathlabs Ltd Q3FY25; 20% rise in Profits

Dr. Lal PathLabs Limited is one of India’s leading consumer healthcare brand in diagnostic services. It has an integrated nationwide…

Sanofi India Ltd Q3FY25; 34% fall in Profits

Sanofi India Ltd Q3FY25; 34% fall in ProfitsSanofi India Ltd Q3FY25; 34% fall in Profits

Sanofi India Limited is amongst the leading multinational companies in the Indian Pharmaceutical Market. It offers a wide array of…

Cipla Ltd Q3FY25; 47% rise in Profits

Cipla Ltd Q3FY25; 47% rise in ProfitsCipla Ltd Q3FY25; 47% rise in Profits

Cipla is engaged in the Business of Pharmaceuticals.(Source : 202003 Annual Report Page No:157) Financial Results: Cipla Ltd reported Revenues…

Pfizer Ltd Q3FY25; 2% fall in Profits

Pfizer Ltd Q3FY25; 2% fall in ProfitsPfizer Ltd Q3FY25; 2% fall in Profits

Pfizer Ltd is engaged in manufacturing, marketing, trading and export of pharmaceutical products. It manufactures products through its own facility…

Aurobindo Pharma Ltd Q3FY25; 10% fall in Profits

Aurobindo Pharma Ltd Q3FY25; 10% fall in ProfitsAurobindo Pharma Ltd Q3FY25; 10% fall in Profits

Aurobindo Pharma is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.(Source : 202003…

Astrazeneca Pharma India Ltd Q3FY25; 69% fall in Profits

Astrazeneca Pharma India Ltd Q3FY25; 69% fall in ProfitsAstrazeneca Pharma India Ltd Q3FY25; 69% fall in Profits

AstraZeneca Pharma India Ltd is engaged in the business of manufacture, distribution and marketing of pharmaceutical products. Financial Results: Astrazeneca…

Ipca Laboratories Ltd Q3FY25; 25% rise in Profits

Ipca Laboratories Ltd Q3FY25; 25% rise in ProfitsIpca Laboratories Ltd Q3FY25; 25% rise in Profits

Ipca Laboratories is engaged in the manufacturing and marketing of pharmaceuticals. Financial Results: Ipca Laboratories Ltd reported Revenues for Q3FY25…

Alkem Laboratories Ltd Q3FY25; 6% rise in Profits

Alkem Laboratories Ltd Q3FY25; 6% rise in ProfitsAlkem Laboratories Ltd Q3FY25; 6% rise in Profits

Alkem Laboratories is engaged in pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale…

Alembic Pharmaceuticals Ltd Q3FY25; 23% fall in Profits

Alembic Pharmaceuticals Ltd Q3FY25; 23% fall in ProfitsAlembic Pharmaceuticals Ltd Q3FY25; 23% fall in Profits

Alembic Pharmaceuticals is in the business of development, manufacturing, and marketing of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients.…

Ajanta Pharma Ltd Q3FY25; 11% rise in Profits

Ajanta Pharma is primarily engaged in development, manufacturing and marketing of speciality pharmaceutical quality finished dosages.(Source : 202003-01 Annual Report…

Abbott India Ltd Q3FY25; 88% fall in Profits

Abbott India Ltd is one of the leading multinational pharmaceutical companies in India and sells its products through independent distributors…

ZYDUSLIFE Q3 2024-2025 Call Highlights: Profit Jump, Robust Margins & Expansion Plans!

Zydus Lifesciences Ltd., a leading Indian Pharmaceutical company, in its Q3 earnings call discussed strong performance across multiple segments, with…

DIVISLAB Q3 2024-2025 Call Highlights: Expansion Plans, Generics Growth, and API Challenges!

Divi's Laboratories Ltd., an Indian multinational pharmaceutical company that manufactures and exports API's, Intermediates and Nutraceutical ingredients, in its Q3…

Granules India Ltd Q3FY25; 6% fall in Profits

Granules India Ltd and its subsidiaries are primarily involved in the manufacturing and selling of Active Pharma Ingredients (APIs), Pharmaceutical…

SUNPHARMA Q3 2024-2025 Call Highlights: India Leads, US Slows, Specialty Expands!

Sun Pharmaceutical Industries Ltd., the fourth largest specialty generic pharmaceutical company in the world, in its Q3 earnings call discussed…

Dr Reddys Laboratories Ltd Q3FY25; 2% rise in Profits

Dr. Reddy's Laboratories Ltd is a leading India-based pharmaceutical company which offers a portfolio of products and services, including Active…

Glenmark Pharmaceuticals Ltd Q3FY25; 88% rise in Profits

Glenmark Pharmaceuticals Ltd is a global research-led pharmaceutical company with presence across generics, Specialty and OTC business with operations in…

CIPLA Q3 2024-2025 Call Highlights: EBITDA Growth, Launch Delays, & Market Strategies!

Cipla Ltd., a leading pharmaceutical company from India that manufactures and distributes branded medicines, generics and active pharmaceutical ingredients across…

Jubilant Pharmova Ltd Q3FY25; 53% rise in Profits

Jubilant Pharmova Ltd is an integrated global pharmaceuticals company having three business segments i.e. pharmaceuticals, contract research and development services…